Literature DB >> 6708975

Therapy of parenchymal brain cysticercosis with praziquantel.

J Sotelo, F Escobedo, J Rodriguez-Carbajal, B Torres, F Rubio-Donnadieu.   

Abstract

Twenty-six patients with cysticercosis of the brain parenchyma were treated with the antihelmintic agent praziquantel (50 mg per kilogram of body weight daily for 15 days). During treatment a strong inflammatory reaction occurred, as evidenced by increased protein and cells in the cerebrospinal fluid. This finding correlated with headache, exacerbation of neurologic symptoms, and edema and inflammation around cystic lesions. After three months of treatment all patients had improved clinically, and 13 (50 per cent) were asymptomatic. The total number of cysts on CT scans had decreased from 152 at the beginning of treatment to 51, and the mean diameter of cysts was reduced by 72 per cent. CT scans showed improvement in 25 of the 26 patients, with total remission of all cysts in nine. Seventeen control patients followed with CT studies for a mean of 9 +/- 2 months had no spontaneous remission of lesions, and in many cases the scans showed worsening during the observation period. Our results indicate that praziquantel is effective in cysticercosis of the brain parenchyma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6708975     DOI: 10.1056/NEJM198404193101601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  54 in total

1.  High-dose praziquantel with cimetidine for refractory neurocysticercosis: a case report with clinical and MRI follow-up.

Authors:  T Yee; J A Barakos; R T Knight
Journal:  West J Med       Date:  1999-02

2.  Interaction between grapefruit juice and praziquantel in humans.

Authors:  Nelly Castro; Helgi Jung; Roberto Medina; Dinora González-Esquivel; Mario Lopez; Julio Sotelo
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Neurocysticercosis.

Authors:  Oscar H Del Brutto
Journal:  Neurohospitalist       Date:  2014-10

4.  Dexamethasone increases plasma levels of albendazole.

Authors:  H Jung; M Hurtado; M T Medina; M Sanchez; J Sotelo
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

5.  Cysticercosis.

Authors:  J F Bale
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

6.  Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies.

Authors:  A Flisser; D Gonzalez; A Plancarte; P Ostrosky; R Montero; A Stephano; D Correa
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

7.  Neurocysticercosis.

Authors:  Christopher M DeGiorgio; Marco T Medina; Reyna Durón; Chi Zee; Susan Pietsch Escueta
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

8.  Effect of praziquantel on intraocular cysticercosis: a case report.

Authors:  P Kestelyn; H Taelman
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

9.  Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel.

Authors:  B Estañol; H Juárez; M del C Irigoyen; D González-Barranco; T Corona
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 10.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.